Literature DB >> 22160848

P2X3 receptor expression by HEK cells conditions their survival.

Lucio Apicella1, Elsa Fabbretti.   

Abstract

On nociceptive neurons, one important mechanism to generate pain signals is the activation of P2X3 receptors, which are membrane proteins gated by extracellular ATP. In this work, we have studied the recovery of recombinant P2X3 receptor expression in human embryonic kidney (HEK) cells. Our data demonstrated that HEK cells were not permissive for stable P2X3 expression, since the significant time-dependent cell loss. In vivo treatment with P2X3 receptor antagonist limited the effect. The expression of a single P2X3 point mutant Y393A, also largely accelerated cell death. We suggest the requirements of a permissive intracellular molecular machinery for appropriate receptor expression. The present report suggests that despite HEK cells are often used as recombinant expression system for the study a variety of receptors function, they represent a limiting permissive environment for P2X3 receptors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160848      PMCID: PMC3350583          DOI: 10.1007/s11302-011-9285-0

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  27 in total

Review 1.  International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.

Authors:  B S Khakh; G Burnstock; C Kennedy; B F King; R A North; P Séguéla; M Voigt; P P Humphrey
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

2.  Experimental and modeling studies of desensitization of P2X3 receptors.

Authors:  Elena Sokolova; Andrei Skorinkin; Igor Moiseev; Andrei Agrachev; Andrea Nistri; Rashid Giniatullin
Journal:  Mol Pharmacol       Date:  2006-04-20       Impact factor: 4.436

3.  A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat.

Authors:  Michael F Jarvis; Edward C Burgard; Steve McGaraughty; Prisca Honore; Kevin Lynch; Timothy J Brennan; Alberto Subieta; Tim Van Biesen; Jayne Cartmell; Bruce Bianchi; Wende Niforatos; Karen Kage; Haixia Yu; Joe Mikusa; Carol T Wismer; Chang Z Zhu; Katharine Chu; Chih-Hung Lee; Andrew O Stewart; James Polakowski; Bryan F Cox; Elizabeth Kowaluk; Michael Williams; James Sullivan; Connie Faltynek
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

4.  The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism.

Authors:  Lizzia Raffaghello; Paola Chiozzi; Simonetta Falzoni; Francesco Di Virgilio; Vito Pistoia
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

5.  Evidence for the existence of P2Y1,2,4 receptor subtypes in HEK-293 cells: reactivation of P2Y1 receptors after repetitive agonist application.

Authors:  Wolfgang Fischer; Heike Franke; Helke Gröger-Arndt; Peter Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-16       Impact factor: 3.000

6.  Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways.

Authors:  R S Ostrom; C Gregorian; P A Insel
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

Review 7.  Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF.

Authors:  Rashid Giniatullin; Andrea Nistri; Elsa Fabbretti
Journal:  Mol Neurobiol       Date:  2008-05-06       Impact factor: 5.590

8.  [3H]A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2/3 and P2X3 receptors.

Authors:  Michael F Jarvis; Bruce Bianchi; John T Uchic; Jayne Cartmell; Chih-Hung Lee; Michael Williams; Connie Faltynek
Journal:  J Pharmacol Exp Ther       Date:  2004-03-15       Impact factor: 4.030

9.  Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration.

Authors:  Steve McGaraughty; Carol T Wismer; Chang Z Zhu; Joseph Mikusa; Prisca Honore; Katharine L Chu; Chih-Hung Lee; Connie R Faltynek; Michael F Jarvis
Journal:  Br J Pharmacol       Date:  2003-11-17       Impact factor: 8.739

10.  Identification of negative residues in the P2X3 ATP receptor ectodomain as structural determinants for desensitization and the Ca2+-sensing modulatory sites.

Authors:  Elsa Fabbretti; Elena Sokolova; Lara Masten; Marianna D'Arco; Alessandra Fabbro; Andrea Nistri; Rashid Giniatullin
Journal:  J Biol Chem       Date:  2004-10-08       Impact factor: 5.157

View more
  1 in total

Review 1.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.